MLLT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.28816965375245E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.36179994953056E-09 |
Normal-vs-Stage2 |
1.40210000054708E-07 |
Normal-vs-Stage3 |
2.7276958469713E-11 |
Normal-vs-Stage4 |
1.55699997339553E-09 |
Stage1-vs-Stage2 |
8.147900E-02 |
Stage1-vs-Stage3 |
6.195500E-03 |
Stage1-vs-Stage4 |
6.347900E-02 |
Stage2-vs-Stage3 |
9.214800E-01 |
Stage2-vs-Stage4 |
6.970400E-01 |
Stage3-vs-Stage4 |
6.546000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63125069008174E-12 |
Normal-vs-AfricanAmerican |
1.517920E-02 |
Normal-vs-Asian |
2.802900E-04 |
Caucasian-vs-AfricanAmerican |
9.338200E-03 |
Caucasian-vs-Asian |
8.553000E-01 |
AfricanAmerican-vs-Asian |
4.305600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.12887477143886E-12 |
Normal-vs-Female |
3.88910015303168E-10 |
Male-vs-Female |
3.213800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.832300E-04 |
Normal-vs-Age(41-60Yrs) |
1.44339984409214E-10 |
Normal-vs-Age(61-80Yrs) |
4.68758365457234E-12 |
Normal-vs-Age(81-100Yrs) |
2.9633000000473E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.723000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.228400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.511600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.505600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.294400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.443000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.922000E-01 |
Normal-vs-Grade 2 |
3.25430016268058E-10 |
Normal-vs-Grade 3 |
1.74710246270138E-11 |
Normal-vs-Grade 4 |
5.84759999977535E-07 |
Grade 1-vs-Grade 2 |
1.256560E-03 |
Grade 1-vs-Grade 3 |
2.16599999999234E-05 |
Grade 1-vs-Grade 4 |
3.059700E-03 |
Grade 2-vs-Grade 3 |
4.053600E-02 |
Grade 2-vs-Grade 4 |
8.785400E-01 |
Grade 3-vs-Grade 4 |
1.904210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.37959976775903E-10 |
Normal-vs-ccB subtype |
3.92570420615357E-11 |
ccA subtype-vs-ccB subtype |
9.833200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.72639680329212E-12 |
Normal-vs-N1 |
7.203400E-04 |
N0-vs-N1 |
9.488800E-01 |
|
|